Sickle cell disease can be fatal. In the United States, the average life expectancy for someone with sickle cell disease is about 53 years, roughly two decades shorter than the general population. The disease causes progressive damage to organs over time, and its most dangerous complications can be life-threatening at any age. However, survival has improved dramatically over the past few decades, and new treatments are pushing those numbers further.
How Sickle Cell Disease Causes Death
Sickle-shaped red blood cells are stiff and sticky. Instead of flowing smoothly through blood vessels, they clump together and block blood flow. Over time, this starves organs of oxygen and causes cumulative damage. The disease also destroys red blood cells faster than the body can replace them, leading to chronic anemia that compounds the problem.
Infection is the single leading cause of death, responsible for roughly 33 to 48% of sickle cell fatalities across all age groups. The spleen, which normally filters bacteria from the blood, is one of the first organs damaged by sickle cells. Without a functioning spleen, even common infections can become overwhelming. Stroke accounts for about 10% of deaths, and kidney failure, blood clots in the lungs, and complications from treatment make up most of the rest.
Acute Chest Syndrome: The Most Dangerous Crisis
Acute chest syndrome is the single most common cause of death in people with sickle cell disease, responsible for about 25% of all deaths. It happens when sickle cells block blood vessels in the lungs, causing chest pain, fever, and difficulty breathing. The mortality rate per episode is about 4.3% in adults and 1.1% in children.
Several things can trigger it. A pain crisis can cause bone marrow and fat particles to break loose and travel to the lungs, setting off a chain reaction of blockages. Infections, asthma flares, surgery, and even medications that cause shallow breathing can also be triggers. Because the lungs are already receiving less oxygen, the low-oxygen environment causes even more red blood cells to sickle, creating a dangerous feedback loop.
Long-Term Organ Damage
Even between crises, sickle cell disease quietly damages organs. The brain and kidneys are especially vulnerable. The majority of adults with sickle cell disease have some degree of brain injury that worsens with age. Without screening and preventive treatment, about 10% of children with the most severe form will have a full stroke before adulthood, and another 22% will have silent brain infarcts, small areas of damage that don’t cause obvious symptoms but can affect thinking and memory.
Kidney disease develops in about 25% of older adults with sickle cell disease and is responsible for half of their deaths. The kidneys are particularly sensitive because their internal blood vessels are tiny and easily blocked. Chronic oxygen deprivation triggers inflammation and scarring that gradually destroys kidney function. Lung disease, including pulmonary hypertension (high blood pressure in the arteries of the lungs), is another major contributor to declining health over time.
Childhood Survival Has Improved Dramatically
In the United States, about 94% of children with the most severe form of sickle cell disease (HbSS) now survive to age 18. For milder forms, that number reaches 98%. These figures represent a massive improvement from just a few decades ago, driven largely by newborn screening, preventive antibiotics, and vaccinations that protect against the infections that once killed many children in their first few years of life.
The picture is starkly different in sub-Saharan Africa, where the vast majority of sickle cell births occur. Without widespread newborn screening or access to basic treatments, an estimated 50 to 90% of children born with sickle cell disease in the region die before their fifth birthday, most without ever receiving a diagnosis.
Treatments That Extend Life
Hydroxyurea, a daily oral medication, is the backbone of sickle cell treatment. It works by boosting production of fetal hemoglobin, a form of hemoglobin that resists sickling. In a 17-year study, patients on hydroxyurea had a 73% lower death rate compared to those treated without it. The death rate was about 10% in the hydroxyurea group versus 25% in the conventionally treated group over the study period.
Preventive blood transfusions can reduce the risk of stroke in children tenfold, from 10% per year down to about 1% per year in high-risk patients identified through ultrasound screening of blood flow in the brain.
Two gene therapies, Casgevy and Lyfgenia, were approved by the FDA in late 2023 for patients 12 and older with severe disease. In clinical trials, 97% of patients who received Casgevy and 88% of those who received Lyfgenia were free of severe pain crises for at least a year after treatment. Both require intensive chemotherapy beforehand and carry significant side effects. Lyfgenia carries an FDA boxed warning because some patients developed leukemia after treatment. These therapies are still new, expensive, and limited in availability, but they represent the closest thing to a functional cure outside of a bone marrow transplant.
Sickle Cell Trait Is Different, but Not Risk-Free
Sickle cell trait, where a person carries one copy of the sickle gene instead of two, is not the same as sickle cell disease. People with the trait don’t experience pain crises or organ damage under normal circumstances. But the trait is not completely harmless. Sudden deaths have been documented during extreme physical exertion, particularly in military recruits and athletes. U.S. Army research has shown that red blood cells can begin sickling within minutes of maximal exercise in people with the trait.
The risk comes from a combination of factors: sustained high-intensity exercise, dehydration, heat, high altitude, fatigue, and illness. When muscles are pushed hard enough, oxygen levels in the blood drop and acid builds up, triggering the same sickling process that occurs in full disease. This can lead to a rapid breakdown of muscle tissue and organ failure. The key difference is that these events are rare, situational, and largely preventable with proper pacing, hydration, and rest during intense physical activity.